Five‐Year Outcomes and Disease Trajectories in Moderate‐to‐Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort
Journal of Gastroenterology and Hepatology · 2026-08 · 41 (8) · 2338-2348
DOI: 10.1111/jgh.70508 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 29.06.2026. Verfasst von Byong Duk Ye und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Kore…. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Johnson & Johnson Korea.
Abstract (Originalsprache)
Background and Aim The incidence of ulcerative colitis (UC) has been increasing in Asia. Comprehensive data on the long‐term course of moderate‐to‐severe UC remain scarce. This study investigated the clinical outcomes and factors associated with a disabling disease course in Korean patients with moderate‐to‐severe UC.
Methods
The moderate‐to‐severe ulcerative colitis in Korea study was a prospective, multicenter, hospital‐based inception cohort study that enrolled patients with newly diagnosed moderate‐to‐severe UC between August 2014 and February 2017. Clinical outcomes and factors associated with a disabling disease course were evaluated over 5 years.
Results
Among 353 patients included, the median follow‐up duration was 4.9 (interquartile range, 2.1–5.0) years, and 214 patients (60.6%) completed the 5‐year follow‐up. At 5 years, the cumulative rates of outcomes were clinical relapses, 62.9%; proximal disease extension, 29.5%; and UC‐related hospitalization, 22.4%. Colectomy was required in two patients (0.6%), without mortality. A disabling disease course occurred in 171 patients (48.4%), with cumulative probabilities of 41.0%, 51.1%, and 53.9% at 12, 36, and 60 months, respectively. Elevated baseline white blood cell count was independently associated with a disabling disease course (adjusted hazard ratio: 1.06; 95% confidence interval: 1.00–1.12; p = 0.035). Five distinct partial Mayo score–based disease trajectory clusters were identified, demonstrating clear prognostic separation.
Conclusions
While Korean patients with moderate‐to‐severe UC showed a benign structural disease course with minimal colectomy rates, approximately half experienced a disabling disease course. The identified disease trajectories provide a novel framework for risk stratification and personalized management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
- Department of Gastroenterology, Center for Crohn's and Colitis, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, South Korea.
- Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Internal Medicine, Nowon Eulji Hospital, Eulji University School of Medicine, Seoul, South Korea.
- Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea College of Medicine, Suwon, South Korea.
- Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
ORCID-Profile: Byong Duk Ye, Jae Hee Cheon, Chang Kyun Lee
Förderung
- Johnson & Johnson Korea
Zitieren
APA
Ye, B. D., Kim, H. J., Park, D. I., Park, Y. S., Lee, K. M., Im, J. P., Jung, S. A., Jeen, Y. T., Cha, J. M., Cheon, J. H., Hong, S. N., Kim, Y., Choi, J. M., Lee, Y., & Lee, C. K. (2026). Five‐Year Outcomes and Disease Trajectories in Moderate‐to‐Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort. Journal of Gastroenterology and Hepatology, 41(8), 2338-2348. https://doi.org/10.1111/jgh.70508
Vancouver
Ye BD, Kim HJ, Park DI, Park YS, Lee KM, Im JP, et al. Five‐Year Outcomes and Disease Trajectories in Moderate‐to‐Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort. Journal of Gastroenterology and Hepatology. 2026;41(8):2338-2348. doi:10.1111/jgh.70508
BibTeX
@article{Ye2026,
author = {Ye, Byong Duk and Kim, Hyo Jong and Park, Dong Il and Park, Young Sook and Lee, Kang-Moon and Im, Jong Pil and Jung, Sung-Ae and Jeen, Yoon Tae and Cha, Jae Myung and Cheon, Jae Hee and Hong, Sung Noh and Kim, Youngdoe and Choi, Jong Min and Lee, YoungJa and Lee, Chang Kyun},
title = {Five‐Year Outcomes and Disease Trajectories in Moderate‐to‐Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {8},
pages = {2338--2348},
doi = {10.1111/jgh.70508}
}
EUVIMED